Меню
Набор скоро начнётся NCT07737314

Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study

Без фазы С лечением Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Survey Administration, Electronic Health Record Review.
Кому может быть актуально
Состояния в реестре: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Обзор

This clinical trial will evaluate the feasibility, acceptability, and potential efficacy of a palliative care pharmacist-led group telehealth opioid education session for palliative care patients prescribed opioids for cancer-related pain. While opioids are commonly used in palliative care settings to manage cancer-related pain, their significant side effects, complicated administration requirements, and concerns about addiction can make it challenging for patients to use opioids safely and effectively. Some patients may even avoid opioids altogether because of these concerns, even when opioids are clinically indicated, leading to poor symptom control. To address these challenges, a telehealth education session was developed as a clinical initiative by a palliative care pharmacist, addressing safe and effective opioid management. Educational priorities and session content were informed by a survey of interdisciplinary palliative care clinicians that identified barriers and facilitators to opioid education and key patient educational needs. Patients scheduled to attend a pharmacist-led group telehealth opioid education session who enroll in the study will complete a survey before the session and another survey afterward. This study will assess the feasibility and acceptability of delivering the intervention, as well as its preliminary effects on opioid knowledge and self-efficacy. If feasible and acceptable, this pharmacist-led telehealth education model could represent a scalable strategy to improve opioid management for patients with cancer-related pain.

Подробное описание

OUTLINE:

Patients scheduled to attend a pharmacist-led group telehealth opioid education session who enroll in the study will complete a survey before the session and another survey afterward. After attending the pharmacist education session, patients will receive a patient education handout summarizing the educational content.

After attending the pharmacist education session, participants will complete the final survey within 1 month, concluding their participation.

Вмешательства

  • Другое Survey Administration
    Ancillary studies - pre- and post-session surveys to assess opioid knowledge and self-efficacy, and post-session to assess session acceptability
  • Другое Electronic Health Record Review
    Ancillary studies

Первичные конечные точки

  • Percentage of referred patients who attend pharmacist education session (Feasibility) [Срок оценки: Up to 6 months]
  • Participant score on the "general acceptability" item of the Theoretical Framework of Acceptability questionnaire [Срок оценки: Up to 1 month post-session]

Критерии участия

Критерии включения

  • Age ≥ 18 years, consistent with the population of patients treated at Fred Hutch Cancer Center
  • A cancer diagnosis
  • Established care in the Fred Hutch Palliative Care Clinic (≥ 1 visit with a Fred Hutch palliative care physician or advanced practice provider within the past 12 months)
  • Prescribed opioids, defined as either ≥ 1 opioid prescription within the past 6 months documented in the Washington Prescription Drug Monitoring Program (PDMP), or a new opioid prescription initiated by the referring palliative care provider at the time of referral
  • Ability to understand and willingness to agree to an electronic consent document
  • Enrolled in MyChart and ability to participate in a telehealth video visit

Критерии исключения

  • Patients who prefer a language other than English for healthcare, as the session will be conducted live and cannot currently be offered in other languages

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Не применимо
Модель
Одна группа
Маскирование
Открытое
Основная цель
Поддерживающая терапия

Центры проведения

США · 1 центр
  • Fred Hutch/University of Washington Cancer Consortium — Seattle

Идентификаторы

NCT: NCT07737314 · RG1126526 · NCI-2026-05093 · 0021316 · P30CA015704

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗